Cardiotoxicity of emetine dihydrochloride by calcium channel blockade in isolated preparations and ventricular myocytes of guinea-pig hearts

British Journal of Pharmacology

Volumn 117, Issue 2, 1996, Pages 377-383

  Lemmens Gruber, R ^a   Karkhaneh, A ^a   Studenik, C ^a   Heistracher, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiomyocyte; Cardiotoxicity; Emetine; Heart muscle preparations; L type calcium channel current

Indexed keywords

ANTIAMEBIC AGENT; BARIUM ION; CALCIUM CHANNEL; CALCIUM ION; EMETINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CARDIOTOXICITY; CONCENTRATION RESPONSE; DEPOLARIZATION; FEMALE; GUINEA PIG; HEART ATRIOVENTRICULAR NODE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE POTENTIAL; HEART PAPILLARY MUSCLE; HEART VENTRICLE WALL; INOTROPISM; MALE; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; SINUS NODE;

EID: 0030045545     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15202.x     Document Type: Article

References (38)

1. ADLER, G.A., WALINSKY, P., KRALL, R.A. & CHO, S.Y. (1980). Death resulting from ipecac syrup poisoning. J. Am. Med. Assoc., 243, 1927-1928.
2. BAYER, R., HENNEKSS, R., KAUFMANN, R, & MANNHOLD, R. (1975). Inotropic and elect rophysiological actions of verapamil and D600 in mammalian myocardium. 1. Pattern of inotropic effects of the racemic compounds. Naunyn Schmied. Arch. Pharmacol., 290, 49-68.
3. BAYER, R., RODENKIRCHEN, R., KAUFMANN, R., LEE, J.H. & HENNEKES, R. (1977). The effects of nifedipine on contraction and monophasic action potential of isolated cat myocardium. Naunyn Schmied. Arch. Pharmacol., 301, 29-37.
4. BEELER, G.W. & REUTER, H. (1977). Reconstruction of the action potential of ventricular myocardial fibres. J. Physiol., 268, 177-210.
5. BIANCHI, A., DE MARINO, V., DE VUEESCHHOUWER, G.R. & MARINO, A. (1965). Effect of emetine on heart, coronary circulation and blood pressure. Arch. Int. Pharmacodyn. Ther., 156, 238-248.
6. BRINK, A.J., KOTZÉ, J.C.N., MULLER, S.P. & LOCHNER, A. (1969). The effect of emetine on metabolism and contractility of the isolated rat heart. J. Pharmacol. Exp. Ther., 165, 251-257.
7. COMBS, A.B. & ACOSTA, D. (1990). Toxic mechanisms of the heart: a review. Toxicil. Pathol., 18, 583-596.
8. CRANEFIELD, P.F., ARONSON, R.S. & WIT, A.L. (1974). Effect of verapamil on the normal action potential and on a calcium-dependent slow response of canine cardiac Purkinje fibres. Circ. Res., 34, 204-213.
9. DRESSER, L.P., MASSEY, E.W., JOHNSON, E.K. & BOSSEN, E. (1993). Ipecac myopathy and cardiomyopathy. J. Neurol. Neurosurg. Psychiatry, 56, 560-562.
10. DROOGMANS, G. & NILIUS, B. (1989). Kinetic properties of the cardiac T-type calcium channel in the guinea-pig. J. Physiol., 419, 627-650.
11. FENWICK, E.M., MARTY, A. & NEHER, K. (1982). Sodium and calcium channels in bovine chromaffin cells. J. Physiol., 331, 599-635.
12. FLECKENSTEIN, A. (1977). Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Anna. Rev. Pharmacol. Topical., 17, 149-166.
13. FRIEDMAN, E.J. (1984). Death from ipecac intoxication in a patient with anorexia nervosa. Am. J. Psychiatry, 141, 702-703.
14. HACHISU, M. & PAPPANO, A.J. (1983). A comparative study of the blockade of calcium-dependent action potentials by verapamil, nifedipine and nimodipine in ventricular muscle. J. Pharmacol. Exp. Ther., 225, 112-120.
15. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch., 391, 85-100.
16. HESS, P., LANSMAN, J.B. & TSIEN, R. (1984). Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature, 311, 538-544.
17. KASS, R.S. (1982). Delayed rectification in the cardiac Purkinje fibre is not activated by intracellular calcium. Biophys. J., 45, 837-839.
18. KASS, R.S. (1984). Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibres. J. Pharmacol. Exp. Ther., 223, 446-456.
19. KAWAI, C., KONISHI, T., MATSUYAMA, F., & OKAZAKI, H. (1981). Comparative effects of three calcium antagonists, diltiazem, verapamil, and nifedipine, on the sinoatrial and atrioventricular nodes. Circulation, 63, 1035-1042.
20. KAWASHIMA, Y. & OCHI, R. (1988). Voltage-dependent decrease in the availability of single calcium channels by nitrendipinc in guinea-pig ventricular cells. J. Physiol., 402, 219-235.
21. si-mediated action potentials. Naunyn Schmied. Arch. Pharmacol., 323, 251-260.
22. KOHLHARDT, M., BAUER, B., KRAUSE, H. & FLECKENSTEIN, A. (1971). Selective inhibition of Ca conductivity of mammalian cardiac fibre membranes by Ca-antagonistic compounds (verapamil, D600). In Proceedings of the 25th Congress of the International Union of Physiological Sciences, Munich 1971, Vol. 9, p. 313. Munich: German Physiological Society.
23. KUNTZER, T., BOGOUSSLAVSKY, J., DERUAZ, J.P., JANZER, R. & REGLI, K. (1989). Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy. J. Neurol., 236, 246-248.
24. LEE, K.S. & TSIEN, R.W. (1983). Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature, 302, 790-794.
25. MARINO, A., COSTA, R. & DE NATALE, G. (1990). La cardiotossicita dell'emetina. Clin. Ter., 133, 131-143.
26. MATEER, J.E.., FARRELL, B.J., CHOU, S.S.M. & GUTMAN, L. (1985). Reversible ipecac myopathy. Arch. Neurol., 42, 188-190.
27. K in ventricular muscle. Experientia, 30, 680-681.
28. MITRA, R. & MORAD, M. (1985). A uniform enzymatic method for dissociation of myocytes from heart and stomachs of vertebrates. Am. J. Physiol., 249, H1056-1060.
29. NABAUER, M., CALLEWAERT, G., CLEEMANN, L. & MORAD, M. (1989). Regulation of calcium release is gated by calcium current, not gating charge, in cardiac myocytes. Science, 244, 800-803.
30. NAKAJIMA, H., HOSHIYAMA, M., YAMASHITA, K. & KIYOMOTO, A. (1975). Effect of diltiazem on electrical and mechanical activity of isolated cardiac ventricular muscle of guinea pig. Jpn. J. Pharmacol., 25, 383-392.
31. PALMER, E.P. & GUAY, A.T. (1985). Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. New Engl. J. Med., 313, 1457-1459.
32. REITER, M. (1967). Die Wertbestimmung inotrop wirkender Arzneimittel am isolierten Papillarmuskel. Arzneim. Forsch., 17, 1249-1253.
33. SALAKO, L.A. & DUROTOYE, A.O. (1971). Observations on the hypotensive response to dehydroemetine. Eur. J. Pharmacol., 14, 200-203.
34. SCHIFF, R.J., WURZEL, C.L., BRUNSON, S.C., KASLOFF, I. & NUSSBAUM, M.P. (1986). Death due to chronic syrup of ipecac use in a patient with bulimia. Pediatrics, 78, 412-416.
35. STEINEGGER, E. & HANSEL, R. (1992). Ipecacuanha-Alkaloide. In Pharmakognosie, Vol. 5, pp. 536-539. Berlin, Heidelberg, New York, London, Paris, Toyko, Hong Kong, Barcelona, Budapest: Springer Verlag.
36. STUIVER, P.C. & VISSER, L.G. (1993). Het amoeboom van de dikke darm en het rectum. Ned. Tijdschr. Geneeskd., 137, 2328-2331.
37. TOHSE, N. (1990). Calcium-sensitive delayed rectifier potassium current in guinea pig ventricular cells. Am. J. Physiol., 258, (Heart Circ. Physiol. 27), H1200-H1207.
38. THYAGARAJAN, D., DAY, B.J., WODAK, J., GILLIGAN, B. & DENNETT, X. (1993). Emetine myopathy in a patient with an eating disorder. Med. J. Aust., 159, 757-760.